Steven Cohen’s GSK GSK Stock Holding History

Steven Cohen’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139M	Buy	+2,652,881	New	+$140M	0.15%	132
2026 Q1	–	Sell	-1,474,951	Closed	-$72.3M	–	4070
2025 Q4	$72.3M	Buy	+1,474,951	New	+$68.8M	0.08%	278
2024 Q2	–	Sell	-543,100	Closed	-$23.3M	–	2092
2024 Q1	$23.3M	Buy	543,100 +518,300	+2,090%	+$21.4M	0.06%	408
2023 Q4	$919K	Buy	+24,800	New	+$890K	﹤0.01%	1419
2023 Q2	–	Sell	-106,100	Closed	-$3.78M	–	2413
2023 Q1	$3.78M	Sell	106,100 -6,365,673	-98%	-$223M	0.01%	840
2022 Q4	$227M	Buy	6,471,773 +1,849,922	+40%	+$61.6M	0.77%	13
2022 Q3	$136M	Buy	4,621,851 +2,657,852	+135%	+$101M	0.54%	25
2022 Q2	$107M	Buy	1,963,999 +1,472,799	+300%	+$81.3M	0.45%	35
2022 Q1	$26.7M	Buy	491,200 +210,720	+75%	+$11.4M	0.11%	252
2021 Q4	$15.5M	Buy	+280,480	New	+$14.6M	0.06%	397
2021 Q1	–	Sell	-204,000	Closed	-$9.38M	–	1044
2020 Q4	$9.38M	Buy	+204,000	New	+$9.37M	0.05%	451
2019 Q4	–	Sell	-32,400	Closed	-$1.73M	–	1062
2019 Q3	$1.73M	Sell	32,400 -851,738	-96%	-$43.8M	0.01%	616
2019 Q2	$44.2M	Buy	884,138 +692,812	+362%	+$34.8M	0.23%	112
2019 Q1	$9.99M	Buy	+191,326	New	+$9.56M	0.05%	404
2017 Q4	–	Sell	-483,535	Closed	-$24.5M	–	969
2017 Q3	$24.5M	Buy	483,535 +403,535	+504%	+$20.5M	0.11%	221
2017 Q2	$4.31M	Buy	+80,000	New	+$4.26M	0.02%	533
2016 Q1	–	Sell	-69,680	Closed	-$3.51M	–	772
2015 Q4	$3.51M	Buy	+69,680	New	+$3.55M	0.03%	466

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Steven Cohen's GSK Position: Q2 2026 in Review

Steven Cohen opened a new position in GSK (GSK) in Q2 2026: 2,652,881 shares worth $139M. The stake represents 0.15% of the portfolio and ranks #132 among its holdings. This is a return to the name: Steven Cohen previously reported a position in GSK as recently as Q4 2025.

Steven Cohen first reported a position in GSK in Q4 2015 and has held it in 17 quarters since. The position peaked at $227M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Steven Cohen held 2,652,881 shares of GSK worth $139M as of Q2 2026.
GSK was a new Steven Cohen position in Q2 2026.
GSK made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #132 holding.
Steven Cohen first reported a position in GSK in Q4 2015 and has held it in 17 quarters since.
Steven Cohen's GSK position peaked at $227M in Q4 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.